All stock lists
Chewy, Inc. (New York Stock Exchange:CHWY)
US · Delayed Price · Currency is USD
Consumer Cyclical · Specialty Retail
21.74-0.19 (-0.87%)
Insider Score
––Not scored
CHWY Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CHWY analyst forecast
CHWY analyst consensus
Moderate Buy12 ratings
Buy 8 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CHWY 12-month price target
$31.00+43.5% upsideaverage of 4 firms
$37.00High
$25.00Low
Best analysts covering CHWY
- Raymond James67%success rate · 6 calls
- Wedbush63%success rate · 16 calls
- Goldman Sachs63%success rate · 8 calls
- Baird60%success rate · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CHWY analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Mizuho | Outperform | — | — | Reiterated | 2026-09-29 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2026-09-11 |
| Goldman Sachs | Buy | $30.00 | +42.3% | Reiterated | 2026-09-11 | |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-09-10 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-09-10 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-09-10 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-09-10 |
| — | Baird | Outperform | — | — | Reiterated | 2026-09-10 |
| — | Rosenblatt | Neutral | — | — | Reiterated | 2026-09-10 |
| Evercore ISI Group | In Line | $25.00 | +20.5% | Downgraded | 2026-09-10 | |
| — | Needham | Hold | — | — | Reiterated | 2026-09-10 |
| Mizuho | Outperform | $32.00 | +33.6% | Reiterated | 2026-09-04 | |
| — | Raymond James | Outperform | — | — | Reiterated | 2026-09-04 |
| Morgan Stanley | Overweight | $37.00 | +49.9% | Reiterated | 2026-08-26 | |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-08-26 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-06-12 |
| — | UBS | Neutral | — | — | Reiterated | 2026-06-11 |
| — | Needham | Hold | — | — | Reiterated | 2026-06-11 |
| — | Baird | Outperform | — | — | Reiterated | 2026-06-11 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-06-11 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-06-11 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-06-11 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-06-11 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-06-11 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-06-03 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-06-02 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-26 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-05-26 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-05-12 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-04-27 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-04-13 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-03-31 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-03-30 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-03-27 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-03-26 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-03-26 |
| — | BNP Paribas | Neutral | — | — | Reiterated | 2026-03-26 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-03-26 |
| — | Wedbush | Outperform | — | — | Reiterated | 2026-03-26 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-03-26 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-03-26 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-03-10 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-03-10 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-03-05 |
| — | Raymond James | Outperform | — | — | Upgraded | 2026-02-19 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-01-13 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-12-11 |
| — | Needham | Hold | — | — | Reiterated | 2025-12-11 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-12-11 |
| — | UBS | Neutral | — | — | Reiterated | 2025-12-03 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-11-24 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-11-04 |
| — | MoffettNathanson | Buy | — | — | Upgraded | 2025-09-25 |
| — | Baird | Outperform | — | — | Reiterated | 2025-09-11 |
| — | Wedbush | Outperform | — | — | Reiterated | 2025-09-11 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-09-11 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-09-11 |
| — | TD Cowen | Buy | — | — | Reiterated | 2025-09-11 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-09-11 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-09-11 |
CHWY earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-25 | 0.09 | 0.09 | $3.27B | $3.26B |
| 2026-06-10 | 0.24 | 0.43 | $3.35B | $3.36B |
| 2026-09-09 | 0.18 | 0.20 | $3.32B | $3.33B |
| 2026-12-09 | 0.38 | 0.00 | $3.34B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
